Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Locally Advanced Pancreas Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT01485744
What this trial is testing

LDE225 With Fluorouracil, Leucovorin, Oxaliplatin, and Irinotecan for Untreated Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Massachusetts General Hospital 39
Early research (Phase 1)Active Not RecruitingNCT04484909
What this trial is testing

NBTXR3 Activated by Radiation Therapy for the Treatment of Locally Advanced or Borderline-Resectable Pancreatic Cancer

Who this might be right for
Borderline Resectable Pancreatic AdenocarcinomaLocally Advanced Pancreatic Ductal AdenocarcinomaResectable Pancreatic Ductal Adenocarcinoma+1 more
M.D. Anderson Cancer Center 24
Not applicableStudy completedNCT04416685
What this trial is testing

A New Anatomical Classification of Portal Vein Location of Pancreas Tumors

Who this might be right for
Pancreatic Neoplasm Malignant Head Primary
Sisli Hamidiye Etfal Training and Research Hospital 43
Not applicableStudy completedNCT03949933
What this trial is testing

Proton and Carbon Ion Radiotherapy for Locally Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Carcinoma
Shanghai Proton and Heavy Ion Center 10
Early research (Phase 1)Study completedNCT02643498
What this trial is testing

A Dose Escalation Trial of Stereotactic Body Radiotherapy (SBRT) After Induction Chemotherapy for Locally Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Memorial Sloan Kettering Cancer Center 11
Testing effectiveness (Phase 2)Study completedNCT00558207
What this trial is testing

Phase 2 Study of ARQ 197 Versus Gemcitabine in Treatment-Naïve Patients With Unresectable Locally Advanced or Metastatic Pancreatic Adenocarcinoma

Who this might be right for
Pancreatic Neoplasms
ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA) 43
Testing effectiveness (Phase 2)Ended earlyNCT01413087
What this trial is testing

Efficacy and Safety of BC-819 and Gemcitabine in Patients With Locally Advanced Pancreatic Adenocarcinoma

Who this might be right for
Pancreas, Adenocarcinoma
Anchiano Therapeutics Israel Ltd. 12
Early research (Phase 1)Study completedNCT00925769
What this trial is testing

ATX Study:A Study of Avastin (Bevacizumab), Tarceva (Erlotinib) and Xeloda (Capecitabine) in Patients With Locally Advanced and/or Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Hoffmann-La Roche 32
Testing effectiveness (Phase 2)WithdrawnNCT01017822
What this trial is testing

Conatumumab, Gemcitabine Hydrochloride, Capecitabine, and Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Radiation Therapy Oncology Group
Testing effectiveness (Phase 2)Looking for participantsNCT02843945
What this trial is testing

Initial Feasibility Study to Treat Borderline Resectable Pancreatic Cancer With a Planar LDR Source

Who this might be right for
Pancreatic Cancer
CivaTech Oncology 80
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07825753
What this trial is testing

Protein-Matched ADC or PDC Umbrella Trial in Advanced Pancreatic and Breast Cancer

Who this might be right for
Advanced or Metastatic Pancreatic AdenocarcinomaAdvanced or Metastatic Breast Cancer (BC)
Fudan University 225
Not applicableAvailableNCT01786850
What this trial is testing

Magnetic Resonance-guided High-intensity Focused Ultrasound Treatment of Locally Advanced Pancreatic Cancer

Who this might be right for
PancreasCancerLocally Advanced Pancreatic Cancer+1 more
University of Roma La Sapienza
Testing effectiveness (Phase 2)Active Not RecruitingNCT06429904
What this trial is testing

Nimotuzumab Plus NALIRIFOX in Locally Advanced Pancreatic Cancer

Who this might be right for
Locally Advanced Pancreatic Cancer
Peking Union Medical College Hospital 31
Testing effectiveness (Phase 2)Study completedNCT00111904
What this trial is testing

Paclitaxel in Treating Patients With Unresectable Locally Advanced or Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Theradex 43
Testing effectiveness (Phase 2)Ended earlyNCT00831493
What this trial is testing

Vorinostat Plus Radiation Therapy in Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
M.D. Anderson Cancer Center 3
Testing effectiveness (Phase 2)UnknownNCT06467565
What this trial is testing

NALIRIFOX as Induction Therapy in LAPC

Who this might be right for
Pancreatic Ductal Adenocarcinoma
The First Affiliated Hospital with Nanjing Medical University 20
Testing effectiveness (Phase 2)Looking for participantsNCT05969171
What this trial is testing

A Single-center, Prospective, Two Cohort Study of Surufatinib Combined With AG or AG in the First-line Treatment of Locally Advanced or Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer Metastatic
Fudan University 65
Not applicableStudy completedNCT00324428
What this trial is testing

TMS for the Treatment of Pancreatic Cancer Pain

Who this might be right for
PainVisceral PainPancreatic Cancer
Beth Israel Deaconess Medical Center 3
Not applicableUnknownNCT06246630
What this trial is testing

In Vitro Organoid Drug Sensitivity-Guided Treatment for Advanced Pancreatic Neuroendocrine Tumor

Who this might be right for
Advanced Pancreatic Neuroendocrine Tumor
Ruijin Hospital 20
Testing effectiveness (Phase 2)Study completedNCT01186731
What this trial is testing

Efficacy and Safety Study of LE-DT to Treat Locally Advanced or Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
INSYS Therapeutics Inc 40
Next Page